KUMIAI CHEMICAL INDUSTRY CO., LTD.
4996・Prime Market・Chemicals
Agrochemicals and Agriculture-Related Business
The core business of Kumiai Chemical, accounting for approximately 81% of consolidated net sales, engaged in the manufacture and sale of agrochemicals.
| Period | Current | Previous | Change |
|---|---|---|---|
| Net sales (H1 FY2026, ending March 2026) | ¥83,646 million | ¥78,432 million (H1 FY2025, ending March 2025) | ↑ |
| Operating income (H1 FY2026, ending March 2026) | ¥9,893 million | ¥9,104 million (H1 FY2025, ending March 2025) | ↑ |
| Share of net sales (H1 FY2026, ending March 2026) | 81.3% | 81.6% (H1 FY2025, ending March 2025) | — |
| Net sales (full year FY2025, ended March 2025) | ¥135,697 million | — | — |
| Operating income (full year FY2025, ended March 2025) | ¥10,581 million | — | — |
Business Details
Manufactures agrochemicals such as insecticides, fungicides, and herbicides. Domestically, sales are conducted mainly through the National Federation of Agricultural Cooperative Associations (Zen-Noh) as the primary channel. Overseas, sales are conducted in each region through consolidated subsidiaries and equity-method affiliates in the US, Belgium, India, Singapore, etc. (and equity-method affiliates in Thailand and Brazil). The business also handles chemicals for non-agricultural land such as golf courses and greening materials. In the first half of FY2026 (ending March 2026), net sales were ¥83,646 million, accounting for 81.3% of consolidated net sales, serving as the group's core revenue base.
Recent Overview
Strong domestic paddy rice demand and accelerated US shipments drove a 6.6% year-on-year increase in first-half net sales.
In the first half of FY2026 (ending March 2026) (November 2025 to April 2026), net sales in the Agrochemicals and Agriculture-Related Business were ¥83,646 million (up ¥5,214 million, or 6.6%, year on year), and operating income was ¥9,893 million (up ¥789 million, or 8.7%, year on year). Domestically, paddy rice herbicides including Efida and paddy rice nursery box treatment products including Dizalta performed well. Overseas, shipments of Axeev to Australia decreased, while shipments to the US increased due to accelerated shipments driven by strengthened sales promotion support ahead of anticipated generic entry.
Key Products
Growth Drivers
- Continued expansion of sales of domestic paddy rice herbicides and nursery box treatment products (Efida and Dizalta)
- Increased shipments of Axeev to the US driven by strengthened sales promotion support (capturing accelerated demand ahead of generic entry)
- Increase in equity in earnings of affiliates (up ¥976 million year on year to ¥2,318 million in H1 FY2026, ending March 2026)
- Progress in launch preparations for new agrochemical pipeline products (Banenta and Ecoark)
- Global sales expansion leveraging the network of overseas subsidiaries and equity-method affiliates
Risks
- Intensified price competition and reduced profit margins due to generic entry into the herbicide Axeev
- Foreign exchange risk (high proportion of overseas sales, with earnings pressure during yen appreciation phases)
- Risk of crude oil and naphtha supply shortages and price surges due to escalating tensions and prolonged conflict in the Middle East
- Geopolitical risks and demand fluctuations in Latin American markets such as Argentina
- Sales constraints due to stricter agrochemical registration regulations and changes in agrochemical policy in various countries
- Price surges in raw materials, fuel, and agrochemical raw materials, and supply chain instability
Last updated: January 27, 2026